Shalby Ltd (NSE: SHALBY, BSE: 540797) is a Ahmedabad, Gujarat-based company in the Assisted Living Facilities and Services industry. With a market capitalisation of ₹1,386 Cr, it ranks #1,424 by market cap among the 6,137 Indian listed companies on FinBizNet, and #2 of 4 in Assisted Living Facilities and Services. At ₹113.39 (as of 25 Oct 2026), the share price is 55.0% below its 52-week high of ₹252.05 and 2.5% above its 52-week low of ₹110.61. The share price is down 55.1% over one year and down 30.5% over three months.
| Current Price | ₹113.39 |
|---|---|
| Market Cap | ₹1,386 Cr |
| NSE Symbol | SHALBY |
| BSE Code | 540797 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Assisted Living Facilities and Services |
| P/E Ratio | 36.3 |
| Return on Equity | 3.47% |
| Return on Assets | 2.83% |
| 52-Week Range | ₹110.61 – ₹252.05 |
| 1-Year Price Change | -55.1% |
| 3-Month Price Change | -30.5% |
| Beta (1Y) | 0.47 |
| Dividend Yield | 0.00% |
| Headquarters | Ahmedabad, Gujarat |
| Website | www.shalby.org |
| Revenue | ₹331 Cr |
|---|---|
| Net Profit | ₹11 Cr |
| Net Margin | 3.2% |
| EPS (Basic) | ₹0.98 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology services; root canal treatment, dental implants, crowns bridges, dentures, orthodontic treatment, dental cosmetic, teeth whitening, pediatric dentistry, dental veneers, gum treatment, and laser dentistry; dermatology; emergency and general medicine; cochlear implants and balloon sinuplasty; gastroenterology, obesity surgery, and endoscopy and laparoscopy; intensive and critical care; nephrology, urology, kidney transplant, dialysis, and interventional nephrology; and general surgery comprising varicose, hernia, and piles surgery. The company also provides liver transplant; maxillofacial surgery; neur
1. Manufacturing of Implants-This segment manufactures implants. 2. Healthcare Services-This segment engages in setting up and managing hospitals and medical diagnostic services. 3. Segment Adjustment-0
1. Healthcare Services-88.5% 2. Manufacturing & Trading of Implants-11.5%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Narayana Hrudayalaya Limited | ₹34,921 Cr | 43.4 | 19.85% | ₹2,684 Cr | -6.7% |
| Shalby Ltd | ₹1,386 Cr | 36.3 | 3.47% | ₹331 Cr | -55.1% |
| Max India Ltd | ₹889 Cr | -6.5 | -31.77% | ₹60 Cr | -28.9% |
| N.G.Industries Ltd | ₹35 Cr | 20.3 | 4.81% | — | -29.2% |
Listed by market capitalisation. Ratios are shown for context only.
Shalby Ltd is trading at ₹113.39, with a market capitalisation of ₹1,386 Cr.
Shalby Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Assisted Living Facilities and Services).
Shalby Ltd has a P/E of 36.3 and a return on equity of 3.47%.
Shalby Ltd is listed on the NSE under the symbol SHALBY and on the BSE under the scrip code 540797.
Shalby Ltd's share price is down 55.1% over one year and down 30.5% over three months. Its 52-week range is ₹110.61 to ₹252.05.
In Q1 FY27, Shalby Ltd reported revenue of ₹331 Cr and net profit of ₹11 Cr, with basic EPS of ₹0.98 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.